Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
so CVR is not like Q stock, then common is big O?
Don't be surprised.
I have always bought and sold the green paper.
Correct.
Any residual value in the last 2 weeks was day traders and maybe the co vacuuming up CVR's cheap to take out of hands of an Icahn type entity, maybe.
now you can try selling your toilet paper stock certificate on ebay.lol
Finally, this day came true.
http://finance.yahoo.com/lookup?s=apcvz
Ji, you're still thinking regular stock. This is a cvr. The only thing it has in common with a normal stock is it can be traded. The company has said all alone that if the minimum is not reached, the payout will be 0. Well, it was cancelled Friday and it did not meet the minimum, so now it is completely worthless, zero, zith, 0.00. Now it's really over, so what you now hold in your account is gone with the wind along with your money. It is now time to count your loss and move on.
When a company buy backs its own shares, it is consider treasury stock. Why would they want to do that? 5 reasons: 1) To provide tax-efficient distributions of excess cash to shareholders. 2) To increase earnings per share and return on equity 3) To provide stock for employee stock compensation contracts or to meet potential merger needs 4) To thwart takeover attempts or to reduce the number of stockholders 5)To make a market in the stock.
Some publicly held corporations have chose to go private. Companies often accomplish such a procedure through a leverage buyout, in which the company borrows money to finance the stock repurchases.
When a company buy backs its own shares, it is consider treasury stock. Why would they want to do that? 5 reasons: 1) To provide tax-efficient distributions of excess cash to shareholders. 2) To increase earnings per share and return on equity 3) To provide stock for employee stock compensation contracts or to meet potential merger needs 4) To thwart takeover attempts or to reduce the number of stockholders 5)To make a market in the stock.
Some publicly held corporations have chose to go private. Companies often accomplish such a procedure through a leverage buyout, in which the company borrows money to finance the stock repurchases.
This went up today, awesome, screw the shorts trying to profit from other people's misery.
Sayonara APCVZ:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-34172
Fresenius Kabi Pharmaceuticals Holding, Inc.
NASDAQ Capital Market
(Exact name of Issuer as specified in its charter and name of Exchange where security is listed and/or registered)
Else-Kroener-Strasse 1 / 61352 Bad Homburg v.d.H. Germany / +49 (6172) 608 0
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
Contingent Value Rights
(Description of class of securities)
Please place and X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
¨ 17 CFR 240.12d2-2(a)(1)
¨ 17 CFR 240.12d2-2(a)(2)
¨ 17 CFR 240.12d2-2(a)(3)
¨ 17 CFR 240.12d2-2(a)(4)
¨ Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. (1)
x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements of the Securities Exchange Act of 1934, Fresenius Kabi Pharmaceuticals Holding, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
March 4, 2011
By: /s/ Richard J. Tajak
Executive Vice President and Chief Financial Officer
Date Richard J. Tajak Title
(1) Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
SEC 1654 (03-06)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Probably the co vacuuming up shares cheap, in case of litigation, in the last 8 days they could have got a high % back cheap enough to be acceptable, versus possible litigation costs.
Maybe to keep future shareholders. Who else would be crazy enough to buy?
Why would the company consider buying back any shares? What benefit would that be to them?
Last day to offload APCVZ, it's still trading, but could cease at any time.
I wonder who's still buying, maybe it's the company trying to help the shareholders recover their investment.
As mentioned previously that mesaq will be a good example of ceased
trading in couple of weeks, well, I don't see bid or offer on it today. I think that grand reaper is already here, but you can still analyze it's trading pattern leading to this debacle. All shorts will never have to cover and all bag holders will never be able to sell rendering stock certificate very harsh toilet paper. GLTA
that is exactly how it is done.
it's difficult to verify it, if you never seen it happen because once stock stops trading, it's ticker and chart is no longer viewable. It's just as if it has never existed at all. I think one
good example of this will be MESAQ. Stock may stop trading when it emerge from BK within next couple of weeks. APCVZ may be another candidate for lights out. GLTA
I agree with DBX5, it make sense that if the stock is cancelled, there's no need to cover. For one thing, shorts make money up front when they sell, then buy back when it drops and profit the difference.
Here's how it works: I borrowed 5000 cvr's from Jim's account and sell to you for $500, then the cvr is cancelled. You can't get your money back because the cvr is not trading anymore, so you are stuck with a worthless pile of junk. I don't have to buy 5000 cvr's to put back into Jim's account because now it's worth $0. Jim never knew I borrowed 5000 from him anyway and now he will never know since he can't sell it. So I walk away with $500 big one without ever spending a penny.
I never heard of people shorting stock and being able to get paid if the stock goes belly up -- it's one thing if it goes to Q but to cease to exist entirely? You sound like you know what you're talking about but I'd need concrete evidence of that. Maybe I'll call my broker tomorrow just to finish off the topic.
this is not a new concept that if you sell shares and company stock ceases trading, you don't have to buy it back. On the flip side if you are long stock that stops trading, your broker will show your position for a week or so after which they will remove it from the account as if you never had it. There is no forced buyback, because to buy back the stock you have to have a person that you buy it from ( seller) and if stock is not trading there is no one that can fill your order. There are plenty of investors who sell stock short and wait for the co. to belly up or reverse split. This way they make 100% on their investment. It does require higher buying power than if you were buying the stock long. As they say when it goes up, sky is the limit, but when it goes down, 0 is the max it can drop to, making all short positions potential of 100% return, but their loss unlimited.
Hmmm I'm not so sure about that but I guess I really don't know. Maybe they have a forced buyback. It would be similar to if you buy a stock and never sell it, you don't make any money.
Once trading is closed, shorts don't have to buy the stock back at all ever, thus they packet entire premium from the sale of the stock.
It will cease to exist.
Well I don't think the theory posted would come true, but indeed there are many shorts. This CVR happens to be listed on NASDAQ, not the pinksheets.
Once trading is closed shorts can no longer cover and will lose all their money if they haven't.
If there are any shorts on this, which I doubt, why would they have to cover at .0001? They will not need to cover when the cvr is cancelled and goes to 0. How much does it cost to buy a zero value cvr.
What I can't understand is why are people still holding this pos since it will be worth 0 on Friday. There's no more suckers out there, so it not going up anymore. The race should now be who will dump the quickest before it's worth ZERO.
whelp, maybe next week
.0155 big collapse--told ya'll
There must be a ton of shorts on this stock hoping it goes to .0001. What would be interesting is if people just continue to trade it as always and not let them cover. A pipe dream, probably, and I'm not in it -- but technically shorts could get killed on this since one day it will be done and no more covering.
be out before March 4th
the board will be kept on until the last day of trading!!!!
any thoughts your welcome to post it here... thanks
Thanks to all parting is sweet sorrow.
Well actually it was a big gamble as most of us well knew. I played it, won some, and lost almost everything with the big tank. I'm responsible for my own investments, no else then myself is guilty for that.
I already have forgotten this thing, in at the next ones...
Thanks for being able to post my thoughts and feelings here. Sharing our laughs and tears. I have learnt a lot. Thanks again for that.
Happy Trading,
CT
Something fishy here! Pay out rumor starting in London was part of a pump a dump scheme it seems to me!
Maybe for the company that put out the PR?
Any chance this gets to .03 before the 4th?
Makes you kindda wonder if the computer generated trade are still working overtime.. and how much did we battle with the super machines..
Technicals...
The irony is, this thing is technically worthless. It's like counterfeit money. Sure, you might be able to spend it, but it technically has no value.
In the end, it's a like an expensive game of hot potato. Somebody is going to be sitting on shares when this thing ceases trading and that will be that.
gekko was most Likely a paid pumper. IMO
APCVZ trading only on technicals.. interesting to watch the volume.. on l2
Hey where did you go? Not one final post? just off into the sunset you go?
President SATED?...wth is sated?...and you're calling us idiots?
Also, you misspelled "parachute" in your sig....ddk
Yukii,
How are you? It's been a while since we last communicated so I decided to drop in on the board and check out what's been going on.
This tanked today like Greece's economy has in recent months and years. I never got in as my money was tied up elsewhere. The recent runup was nice but this looks like toast. That Brazilian Daiquiri that you promised me sounds great now.
Regards from NY,
-bankjob
104,700,000?
Where has it gone?
Owning shares it totally bogus, unless they pay dividends.
The rest conjur up PPS values out of thin air.
Possible, but the #'s were so far away, I think its a waste of time, anger, etc.
CRIXION made out like bandits, and cost them next to nada to post total lies.
theory on today's buying spree
Whoever owns a majority of shares can request an audit. Perhaps a disgrutaled (institional?) holder bought 100 million shares to threaten an audit . . . only to settle out of court for a large sum . . . which small share holders may never see . . .
Any thoughts?
So close yet so far, i see a court challenge coming for a audit just my thought but if this was not even close it would seem like just a gamble lost.
Also would i invest in any company that generated this kind of revenue... the answer would be a resounding yes, split some shares off i will buy !!!
Followers
|
56
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4963
|
Created
|
08/10/09
|
Type
|
Free
|
Moderators |
APCVZ
About Fresenius Kabi Pharmaceuticals Holding, Inc. / APP Pharmaceuticals, Inc.
Fresenius Kabi Pharmaceuticals Holding, Inc., a wholly owned subsidiary of Fresenius Kabi AG, acquired APP Pharmaceuticals, Inc. on September 10, 2008. APP Pharmaceuticals, Inc. is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. The company offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. For more information about APP Pharmaceuticals, Inc., please visit the company's Web site at www.APPpharma.com.
http://www.apppharma.com/index.aspx
Employees
As of December 31, 2009, we had a total of 1,615 full-time employees, of which 65 were engaged in research and development, 411 were in quality assurance and quality control, 843 were in manufacturing, 96 were in sales and marketing and 200 were in administration and finance. None of our employees are represented by a labor union or subject to a collective bargaining agreement. We have not experienced any work stoppage and consider our relations with our employees to be good.
NEWS:
10-29-2010 APP Pharma cleared by FDA for hypertension drug
TEL AVIV (MarketWatch) -- APP Pharmaceuticals Inc., the Schaumburg, Ill., drugmaker, was cleared by the U.S. Food and Drug Administration to market chlorothiazide sodium injection to treat high blood pressure as well as fluid retention for patients with congestive heart failure, cirrhosis of the liver and other ailments. The drug is a generic equivalent to Diuril, which is produced by Lundbeck Pharmaceuticals. /quotes/comstock/11i!hluky (HLUK.Y 18.19, +0.04, +0.22%) APP Pharma is a subsidiary of Fresenius Kabi Pharmaceuticals Holding Inc.
3-19-2010 APP Pharmaceuticals is owned by Fresenius and received FDA approval for their injectable intravenous generic indomethacin late Friday
Here is the link to the FDA website: http://www.fda.gov/Drugs/NewsEvents/ucm1...
The CVRs In connection with the Merger, each APP shareholder was issued one contingent value right of FKP Holdings. The CVRs are intended to give holders an opportunity to participate in any excess Adjusted EBITDA, as defined in the CVR Indenture, generated during the three years ending December 31, 2010, referred to as the “CVR measuring period,” in excess of a threshold amount. Each CVR represents the right to receive a pro rata portion of an amount equal to 2.5 times the amount by which cumulative Adjusted EBITDA of APP and FKP Holdings and their subsidiaries on a consolidated basis, exceeds $1.267 billion for the three years ending December 31, 2010. The maximum amount payable under the CVR Indenture is $6.00 per CVR |
February 23, 2011
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) today filed its Form 10-K for APP which provides an update on the Contingent Value Rights (CVRs) granted to APP stockholders in September 2008 in conjunction with Fresenius Kabi Pharmaceuticals Holding's acquisition of APP.
The company will give formal notice to the NASDAQ Capital Market of its intention to deregister under the Securities Exchange Act of 1934 (the "Exchange Act") and delist the CVRs from the NASDAQ. The Company will also terminate its obligation to file periodic reports, such as a Form 10-K, Form 10-Q or Form 8-K, under the Exchange Act. It is expected that the CVRs will cease trading on NASDAQ on March 4, 2011. The delisting is expected to be made effective by the NASDAQ prior to the end of the first quarter 2011
AFTER HOUR TRADES --> www.nasdaq.com/aspxcontent/ExtendedTradingTrades.aspx
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |